Novartis Malaysia – Michaela Dinboeck, President & Managing Director
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis…
Address: Level 15, CREST, 3 Two Square No. 2, Jalan 19/1 46300 Petaling Jaya Selangor Darul Ehsan, Malaysia
Tel: +60379481888
Web: http://www.my.novartis.com/
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz. We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Novartis offers a wide range of healthcare products through our Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health Divisions. Nearly 100 000 people are working at Novartis to help save lives and improve quality of life. Corporate citizenship at Novartis rests on four pillars: patients, business conduct, people and communities, and environmental care. At Novartis, we often achieve success through close collaboration with partners who share a common vision and complementary strengths. We operate in 140 countries, with our global headquarters in Basel, Switzerland.
Pharmaceuticals: Our goal is to be recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side effects. Vaccines: Novartis is a leader in providing vaccines to fight preventable viral and bacterial diseases as well as diagnostic tools to protect the blood supply. Generics: Sandoz is a global leader in the rapidly growing generics industry, delivering affordable, high-quality medicines to patients worldwide. Over-the-Counter (OTC): Novartis is a world leader in the research, development, production and marketing of self-medication products that do not require prescription. Animal Health: The company focuses on the well-being of companion animals and on the health and productivity of livestock, including cultivated fish. CIBA Vision: Novaris is a global leader in the research, development and manufacturing of contact lenses and lens-care products.
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis…
“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched…
After 61 years of single-party rule, the May 2018 electoral victory of the populist Pakatan Harapan (PH) coalition…
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted…
American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in…
Sherene Azli, CEO of the Malaysia Healthcare Travel Council (MHTC), introduces this unique organization in charge…
Rashidah Ibrahim, executive director of Malaysian Vaccines & Pharmaceuticals (MVP), tells the story of MVP as…
Chuwn Leong Ch’ng, CEO of Thunder Print, presents his company’s strategic role within the Malaysian…
Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond…
Tan Sri Dato’ Ariffin Yusuf, founder and managing director of Primabumi, explains how he came to build Primabumi…
Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or…
Lee Yee Keng, head of healthcare sector of KPMG in Malaysia, highlights the opportunities Malaysia can offer to the…
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in…